Table of Contents Table of Contents
Previous Page  133 / 604 Next Page
Information
Show Menu
Previous Page 133 / 604 Next Page
Page Background

Retreatment fase 3 trial SC20 → 50% responders

44

Chow et al. Lancet Oncol 2014

1 … 128 129 130 131 132 133 134 135 136 137 138 139 … 604  FlippingBook